Plain-English translation of NCT06081881 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some patients who survive a pulmonary embolism (a blood clot in the lung) go on to develop a serious long-term condition called chronic thromboembolic pulmonary hypertension. This study will follow about 100 patients and collect information about their symptoms, test results, and medical history to identify warning signs that doctors can use to catch this condition early.
Most people recover well from a blood clot in the lung, but some develop lasting complications. This condition is treatable if caught early, but it's often missed because early symptoms are vague or nonexistent. By studying patients after their initial blood clot, researchers hope to find clues that help doctors identify who is at risk and diagnose the problem sooner.
You likely qualify if…
You likely don't qualify if…
You will be asked to share your medical records and information about your symptoms and health history related to your blood clot. The study will also involve heart ultrasounds and blood tests to look for signs of the chronic lung condition. The exact schedule of visits is not yet specified, but researchers will track your health over time to see who develops complications.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Egypt
Sponsor
Ester Ashraf Faried Beshay
Enrollment target
~100 participants
Started
January 2025
Primary completion
October 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ester A Faried, resident
Assiut University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.